View Clinical Trial (Medical Research Study)
Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Post-traumatic Stress Disorder (PTSD) - NCT00941629-53705(Clinical Trial 302534)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Madison |
|
State:
|
|
WI |
| Zip Code: |
|
53705 |
| Conditions: |
|
Post-Traumatic Stress Disorder |
| Purpose: |
|
The purpose of this study is to evaluate the equivalence of CPT treatment delivered remotely
via telemental health (TMH) over videoconferencing or via traditional face-to face (FTF)
treatment to veterans who have Post-traumatic Stress Disorder (PTSD) from a military-related
stressor (i.e., combat, sexual assault, non-combat physical assault). The secondary
objective is to determine if patients' ratings of PTSD symptoms, affect, social adjustment,
therapy alliance, treatment satisfaction and therapist satisfaction, are equivalent between
service-delivery conditions (TMH vs. FTF). A final objective is to develop web-based
practice assignments to assist participants in the TMH condition with treatment adherence
(completion of the between- session practice assignments).
|
| Study summary: |
|
PTSD is the most common mental health diagnosis affecting service men and women who have
served in Iraq and Afghanistan (OEF/OIF). Despite unprecedented efforts by the Dept. of
Defense (DoD) and Dept. of Veterans Affairs (VA) to treat these service personnel with
mental disorders, significant gaps in the continuum of care for psychological health remain,
specifically related to which services are offered, where services are offered, and who
receives services. The DoD and VA have also attempted to address problems with accessibility
through the development of a video teleconference (VTC) network to ensure that service
members have access to top-quality specialized medical care regardless of their geographical
location. Provision of medical treatment over VTC is often referred to as telemedicine;
telemental health (TMH) refers to the provision of mental health treatment over the same
system. A handful of studies have shown that psychiatry (primarily medication management)
delivered over TMH systems can be as effective as face-to-face (FTF) treatment as long as
the equipment and band-width are capable of delivering the communication in near real
time.TMH is an increasingly common method of providing psychological treatment to service
members with PTSD and other mental health problems, and yet there are no randomized trials
of TMH provision of an empirically validated treatment for PTSD compared with FTF treatment.
Therefore, this study aims to evaluate the treatment outcomes of patients with PTSD treated
with CPT either remotely via TMH or traditionally in FTF treatment. |
| Criteria: |
|
Inclusion Criteria:
- 18 years of age or older
- Literate in written English
- Fluent in spoken English
- Verified status as an OEF/OIF veteran
- Current PTSD diagnosis
- Index traumatic event related to military services
- If taking psychotropic medication, remains stable
Exclusion Criteria:
- Under 18 years of age
- Not literate in written English
- Not fluent in spoke English
- Current uncontrolled psychotic or bipolar disorder
- Substance dependence
- Current uncontrolled suicidal or homicidal ideation
- Significant cognitive impairment that would interfere with completion of therapy
tasks |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 12, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|